Intelligent Ultrasound has sold its clinical AI business to GE HealthCare
July 2024 — Intelligent Ultrasound Group plc has completed the sale of its clinical AI software business to GE HealthCare for US$52.3 million. This cross-border transaction bolsters GE HealthCare’s ultrasound systems offering by enabling deeper integration of AI solutions to improve clinical workflows, reduce repetitive tasks and simplify examinations.
Intelligent Ultrasound Group plc (AIM: IUG) is one of the world’s leading classroom-to-clinic ultrasound companies, specializing in real-time, high-fidelity virtual reality simulation for the ultrasound training market and artificial intelligence-based clinical image analysis software tools for diagnostic medical ultrasound. Based in Cardiff, UK, and Atlanta, USA, the group has sold its clinical AI business comprising Intelligent Ultrasound Limited, the developer of medical ultrasound software, together with related clinical AI assets.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics and digital solutions provider, delivering integrated systems, services and data analytics to improve hospital efficiency, clinical effectiveness, therapeutic precision and patient outcomes. With more than 125 years of experience, the company advances patient care from diagnosis to therapy and monitoring, while simplifying the patient journey across the care pathway. GE HealthCare operates across imaging, ultrasound and image-guided therapies, patient care solutions and pharmaceutical diagnostics, and is a US$19.6 billion business employing approximately 51,000 people.
Our role in the transaction
Oaklins Cavendish, one of Oaklins’ member firms in the UK, advised Intelligent Ultrasound Group plc on the sale of its clinical AI business to GE HealthCare.
Talk to the deal team
Related deals
Comtax has been acquired by Ryan
Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreNextalia has acquired a majority stake in Witapp
Nextalia SGR S.p.A. has acquired a majority stake in Witapp S.r.l., an Italian company specializing in software development for the digitization of healthcare infrastructure. The acquisition strengthens Nextalia’s track record in technology companies serving the public sector and supports its strategy of investing in businesses operating at the intersection of healthcare digitization and the modernization of public services.
Learn more